Gambro buys back Korean selling rights:
This article was originally published in Clinica
Executive Summary
Gambro, the Swedish-based renal care company, has acquired the sales rights in Korea for certain products from its COBE subsidiary, representing annual sales of $6 million. Seajin Medicare, which has 10 employees, will fold itself into Gambro Korea and its president, KS Chai, will become president of Gambro Korea. He succeeds Bo-Inge Hansson, who moves up to become president, Gambro Asia Pacific. The items concerned include COBE BCT blood component technology and renal care products.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.